Skip to main content

Table 1 Baseline clinical characteristics of patients with cervical tuberculous lymphadenitis

From: Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis

 

All patients (n = 165)

Gender (male)

40 (24.2%)

Age (years, mean ± SD)

42.5 ± 16.1

Previous history of TB

13 (7.9%)

Comorbidity

35 (21.2%)

 Cardiovascular diseases

25 (15.2%)

 Diabetes mellitus

11 (6.7%)

 Chronic renal diseases

7 (4.2%)

 Hematologic malignancy

4 (2.4%)

Duration of lymphadenopathy (months, mean ± SD)

8.2 ± 29.8

Location of cervical lymph node

 Bilateral

14 (8.5%)

 Left side

59 (35.8%)

 Right side

92 (55.8%)

Largest size of the lymph node (mm, mean ± SD)

33.1 ± 24.5

Results of the initial diagnostic work-up

 Compatible with TB on CT scan, n/Na

123/143 (86.0%)

 AFB positive, n/Na

20/96 (20.8%)

 TB culture positive, n/Na

36/80 (45.0%)

 TB PCR positive, n/Na

121/158 (76.6%)

 Histologic findings indicative of TB

136/164 (82.9%)

Paradoxical reaction during treatment

38 (23.0%)

CT scan after 6 months of antituberculous therapy

157 (95.2%)

 Residual lymph nodeb

35 (22.3%)

Duration of antituberculous therapy (months, mean ± SD)

7.9 ± 4.4

  1. aNo. of patients tested
  2. bResidual lymph node was defined as a lymph node larger than 10 mm in diameter with central necrosis, peripheral rim enhancement, or perinodal infiltration on computed tomography scan